Page 139 - எங்களுக்கு தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Current Covid shots provide a high level of protection against hospitalization and death, according to a summary of the efficacy of eight vaccines that showed the Pfizer Inc.-BioNTech SE jab may better at stopping at least two worrisome coronavirus variants. Efficacy against Covid-linked disease averaged about 85% after a full course, rising to almost 100% protection against severe disease, hospitalization or death, Julia Shapiro, Natalie Dean, Ira Longini and colleagues said in a paper released Friday before peer-review and publication. The University of Florida researchers compared data from journal articles and media reports for products that have gone through double-blinded, placebo-controlled, late-stage vaccine trials, as well as observational studies.

South africaUnited kingdomIra longiniJulia shapiroUs national institutes of healthUniversity of floridaAstrazeneca plcPfizer incSinovac biotech ltdSinopharm group coModerna incNovavax incCurrent covidNatalie deanSinopharm groupCovid 19